tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CING Stock Latest News

Cingulate Inc. Delays Quarterly Report Filing
Company AnnouncementsCingulate Inc. Delays Quarterly Report Filing
2d ago
CING
Cingulate Inc CEO Shane Schaffer on Administrative Leave
PremiumCompany Announcements
Cingulate Inc CEO Shane Schaffer on Administrative Leave
2d ago
8K
CING
Cingulate places CEO Schaffer on administrative leave
PremiumThe Fly
Cingulate places CEO Schaffer on administrative leave
2d ago
CING
Cingulate CEO tells Roth COO departure has no meaningful impact on CTx-1301
PremiumThe Fly
Cingulate CEO tells Roth COO departure has no meaningful impact on CTx-1301
8d ago
CING
Cingulate reports termination of Chief Operating Officer
PremiumThe Fly
Cingulate reports termination of Chief Operating Officer
8d ago
CING
Cingulate Inc.’s Strategic Partnerships and NDA Submission Drive Buy Rating
PremiumRatingsCingulate Inc.’s Strategic Partnerships and NDA Submission Drive Buy Rating
9d ago
CING
Cingulate Inc Submits NDA for ADHD Treatment
Premium
Company Announcements
Cingulate Inc Submits NDA for ADHD Treatment
11d ago
8K
CING
Cingulate submits CTx-1301 NDA to FDA
Premium
The Fly
Cingulate submits CTx-1301 NDA to FDA
11d ago
CING
Cingulate Inc. Receives Buy Rating: PDUFA Fee Waiver and Competitive Edge of CTx-1301 Boost Market Prospects
PremiumRatings
Cingulate Inc. Receives Buy Rating: PDUFA Fee Waiver and Competitive Edge of CTx-1301 Boost Market Prospects
18d ago
CING
Cingulate receives $4.3M waiver from FDA for NDA for CTx-1301
PremiumThe Fly
Cingulate receives $4.3M waiver from FDA for NDA for CTx-1301
19d ago
CING
Cingulate Inc’s Recent Unregistered Equity Securities Sales
PremiumCompany Announcements
Cingulate Inc’s Recent Unregistered Equity Securities Sales
22d ago
8K
CING
Cingulate Inc Enters $25M Purchase Agreement with Lincoln Park
PremiumCompany Announcements
Cingulate Inc Enters $25M Purchase Agreement with Lincoln Park
25d ago
8K
CING
Cingulate files to sell 2.5M shares of common stock for holders
PremiumThe FlyCingulate files to sell 2.5M shares of common stock for holders
25d ago
CING
Cingulate appoints Nilay Patel as Chief Legal Officer
Premium
The Fly
Cingulate appoints Nilay Patel as Chief Legal Officer
1M ago
CING
Cingulate Inc Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Cingulate Inc Approves Key Proposals at Annual Meeting
2M ago
8K
CING
Cingulate announces efficacy results from Phase 3 study of CTx-1301
PremiumThe Fly
Cingulate announces efficacy results from Phase 3 study of CTx-1301
3M ago
CING
Cingulate price target lowered to $11 from $12 at Roth Capital
PremiumThe Fly
Cingulate price target lowered to $11 from $12 at Roth Capital
3M ago
CING
Cingulate, Inc. Reports Increased Losses Amid R&D Expansion
PremiumCompany Announcements
Cingulate, Inc. Reports Increased Losses Amid R&D Expansion
3M ago
CING
Cingulate receives formal pre-NDA meeting minutes from FDA for CTx-1301
PremiumThe Fly
Cingulate receives formal pre-NDA meeting minutes from FDA for CTx-1301
3M ago
CING
Cingulate Inc Terminates Grant Agreement with Foundation
PremiumCompany AnnouncementsCingulate Inc Terminates Grant Agreement with Foundation
3M ago
8K
CING
Cingulate Inc. Receives Buy Rating Amid Promising Developments in ADHD Treatment CTx-1301
Premium
Ratings
Cingulate Inc. Receives Buy Rating Amid Promising Developments in ADHD Treatment CTx-1301
4M ago
CING
Cingulate announces results from high-dose fed/fast study of CTx-1301
Premium
The Fly
Cingulate announces results from high-dose fed/fast study of CTx-1301
4M ago
CING

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >